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On several occasions during the past few years, 
the reasons have been analyzed for the failure 
to successfully transpiant livers in humans. 
There is little doublt of the feasibility of the 
procedure since chronic survival in mongrel 
dogs was first achieved after orthotopic hepatic 
homotransplantation in early 1964, an experi- 
ence that has been since repeated in several 
laboratories. Four dogs which received ortho- 
topic liver homogwfts in Denver in that year 
are still alive. None has received any immuno- 
suppressive therapy from the fifth month on- 
ward. 
In spite of this progress, all human recipients 
of either orthotopic or auxiliary liver homo- 
grafts have died within 5 weeks after operation. 
The number of trials is no longer small. In 
Denver, there have been 7 clinical attempts at 
orthotopic homotransplantation and 3 at auxili- 
ary transplantation. In the former group, one 
patient bled to  death during operation; the 
other 6 died after 6.5, 7, 7.5, 10, 22, and 23 
days. After auxiliary transplantation, one pati- 
ent died immediately of a technical compli- 
cation and the other 2 succum~bed 22 and 34 
days later. Similar efforts are known to have 
been made elsewhere, between 10 and 20 in all. 
The care of these patients was made diffi#cult 
by gastrointestinal ulcerations and hemorrhage, 
sepsis, serious electrolyte disorders and swift 
and life threatening intraoperative and post- 
operative changes in blood coagulation. To 
some extent each of these complications was 
ultimately founded upon the inability to either 
obtain immediate good liver function or, alter- 
natively, to maintain it for more than a few 
days or weeks without causing the patient's 
death with excessive immuno~suppression. In 
the first instance, the failure was in not pro- 
viding adequately preserved tissue. In the 
second, the technique of drug therapy did not 
have a sufficient margin of sarety to permit 
long-term survival. The following remarks are 
concerned with efforts to  ameliorate these 
deficiencies. 
Tissue Procurement 
and Preservation 
It is our present view that the greatest deter- 
rents to successful liver transplantation in man 
are concerned with organ procurement and 
storage. The sensit~vity of liver tissue to anoxia 
under normothermic conditions is well known. 
If some means of preservation is not instituted, 
canine livers become unsuitable for transplan- 
tation within 30 minutes after donor death. 
Sicular and Moore (1961) have shown that the 
ability to oxidize glucose is rapidly lost after 
30 to 60 minutes. 
In dogs, these adverse effects can be delayed 
and minimized during the period of homograft 
devascularization by inducing donor hypo- 
thermia in advance of operation, and by further 
cooling the graft with intraportal infusion of 
chilled electrolyte solution (24°C) .  Livers so 
prepared regularly provide good [unction if 
their blood supply is reestablished in the recipi- 
ent within 2 hours. For laboratory experiments, 
this is ample time since donor and recipient 
operations can be precisely coordinated. 
For clinical transplantation the situation is 
quite different. The donor is usually normo- 
themic. Furthermore, there is a period of fail- 
ing tissue perfusion before the death o~f the 
donor except under the most extraordinary 
circumstances. Finally, some minutes are re- 
quired after death is pronounced before the 
organ can be cooled by intraportal infusion of 
a cold fluid or by other emergency means. A 
starting point thus exists at which the margin 
of acceptable ischemia has already been partly 
used up. 
The technical requirements for the recipient 
operation compound the drlernrna, whether an 
orthotopic or an auxiliary procedure is contem- 
plated. Bleeding problems due to poor hepatic 
function are to be expected. Patients who need 
either kind of homograft almost invariably 
have portal hypertension. The technical require- 
ments for preparation of a bed for an auxiliary 
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organ may be tedious. Those necessary for re- 
moval of the patient's diseased liver for an 
orthotopic transplantation are even more for- 
midable In either case, efforts to proceed with 
speed are apt to lead to uncontrollable hemor- 
rhage. A number of hours may be required 
before it is possible to even begin the vascular 
anastomoses. 
In some of the early attempts at orthotopic 
transplantation in man, these problems led to 
use of staged procedures. At a first operation, 
the major structures enterlng and leavlng the 
liver were skeletonized. Later, when a cadaveric 
organ became available, the incision was re- 
opened. the dlseased liver quickly removed, and 
the homograft inserted. The approach had se- 
rious disadvantages. These ill pat~ents did not 
well tolerate 2 consecutive procedures of such 
magnitude. In addition, it could not be predic- 
ted at the bime of the first intervention when a 
suitable cadaveric donor might arrive. In one 
case, the interval before the definitive opera- 
tion was more than 2 weeks. 
Fortunately, there is now good ev~dence that 
whole organ liver preservation is practical for 
much longer than the limit of 2 hours which 
was alluded to earl~er. Mikaeloff and Kestens 
and their associates (1965) were the first to 
demonstrate this. They perfused dog livers ill 
situ by means of a pump oxygenator into which 
a heat exchanger had been incorporated for 
induction of hypothermia. When the organs 
were removed from the donors 6 hours later 
and transplanted as orthotopic grafts, a number 
of recipients, which were being treated with 
azathioprine lived for several weeks or months. 
However, Kestens has told us that these results 
could not be duplicated if the liver was extir- 
pated and then perfused extracorporally. Ef- 
forts by Marchioro et a1 (1963) to apply a 
simllar but simpler system for whole or lower- 
half cadaver perfusion also resulted in unsatis- 
factory liver preservation. 
Within the last few months, 2 groups of in- 
vestigators have reported benefits of preserva- 
tion wlth a combination of hypothermia, intra- 
vascular perfusion, and hyperbaric oxygenation. 
Slapak ct a1 (1967) stored puppy livers for 24 
hours and inserted them into the neck of adult 
recipients. In 7 of 19 experiments, bile produc- 
tion was noted. The perfusate used d ~ d  not 
conta~n red blood cells. 
Brettschncider and his associates (1967) have 
evaluated the same method in dogs employing 
diluted blood for the perfusate. The adequacy 
of organs stored for 8 to 25 % hours war tested 
by placing them as orthotopic homografts in 
mongrel recipients which were under immuno- 
suppressive therapy. During preservation, the 
temperature and oxygen compression within 
the chamber were 2 4 ° C .  and 40 pounds per 
square inch respectively. The best perfusion 
rate studied was 6 mllgm tissue/hour, d~vlded 
in a 4:l ratio between the portal vein and 
hepatic artery. 
Livers preserved in this way for 8 to 10 
hours performed almost as well as those cooled 
and transplanted without delay. Even after 24 
hours storage, such homografts were good e- 
nough to allow chonic survival in 2 of 5 expe- 
riments. Dev~ations from the above protocol 
were notably less successful. Elimination of 
high oxygen compression, reduction in flow 
rate, omlssion of blood from the perfusate, and 
elimination 04 perfusion all caused a deteriora- 
tion in results. 
When the suboptimal preservation methods 
mere used, the recipients sometimes were able 
to survlve operation but they developed a syn- 
drome which has already been seen after se- 
veral human liver transplantations. A bleeding 
d~athesis during operation was the first sign of 
trouble. In many dogs, this led to immediate 
fatal hemorrhage. In others. it was eventually 
controlled with high doses of epsilon amino 
caproic acid and protarnine. The latter animals 
were slow to arouse from barbiturate anesthe- 
sia. Massive therapy with electrolyte solutions 
and plasma was required for the first day. 
apparently because of the formation of a third 
fluid space. There was a high incidence of 
acute gastrointestinal ulcerations and hemor- 
rhage. These dogs could be kept alive for sev- 
eral days but none was ever able to eat; all 
died within 10 days. 
With immunoelectrophoresis, Kashiwagi el 
a1 (1967) examined the serum protein compo- 
nents in these animals and compared the results 
with those reported earlier by Kukral (1962). 
In untreated dogs which had received optimally 
preserved hon~ografts, the latter author had 
observed heightened protein synthesis for at 
least the first 4 postoperative days as well as 
maintenance of essentially normal serum pro- 
teins. In contrast, Kashiwagi found early reduc- 
tion or even complete disappearance of a 
number d discrete protein moieties in the re- 
cipients of the damaged livers. These tended 
to return, but never completely to normal. In 
such experiments, the combination of ischemic 
injury plus an unanalyzable further insult due 
to subsequent rejection, apparently precluded 
chronic survival. 
The demonstration that l~vers can be kept in 
good condition for at least 8 and often for 24 
hours 1s encouraging, but it would be unreal- 
istic for the reasons cited at the beginn~ng of 
this section to accept these figures as applicable 
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in a clinical setting. No presenttly known tech- 
nique of preservation can resuscitate liver tissue 
which has already been seriously injured. Thus 
the necessity for quickly obtaining and rapidly 
cooling cadaveric livers looms as the most 
important impediment to success. 
Control of Rejection 
The high incidence of infectious complications 
after clinical liver transplantation has made it 
clear that the margin is exceedingly slim be- 
tween desirable and lethal immunosuppression, 
uslng azathioprine and prednisone by the same 
general techniques that have permitted a large 
number of successes after clinical renal trans- 
plantat~on. T h ~ s  does not imply that it is more 
difficult to prevent rejection of livers than of 
kidneys; indeed, experiments in our laboratory 
with the 2 organs have led us to the converse 
conclusion. It probably does mean that a pa- 
tient who is a candidate for liver transplanta- 
tion is more apt to be killed by the side effeots 
of these agents. He is more ill, requires a much 
larger operation, and suffers from a far more 
complicated metabolic disorder than the patient 
with terminal uremia. 
The features of rejection of orthotoplc liver 
homografts have been well described in both 
untreated canine recipients and in dogs modi- 
fied by azathioprine, heterologous antilympho- 
cyte globulin and other agents. By and large, 
the findlngs are analogous to those in other 
rejecting tissues and organs. In unmodified re- 
cipients, there is early invasion by immature 
mononuclear cells which are similar to the 
same kind of cells found in increased numbers 
in the host lymphoid organs. These tend to be 
concentrated around the portal tracts and cen- 
tral veins. Within a few days, mature plasma 
cells and lymphocytes appear. Meanwhile, there 
is necrosls of the hepatic parenchyma, parti- 
cularly around the portal tracts and in the 
centers of the liver lobules. 
Provision of immunosuppression may not pre- 
vent these charges. However, in many treated 
dogs the acute assault upon the homograft 
loses its intensity during the second or third 
weeks. The number of mononuclear cells de- 
creases, and from this point onward the pre- 
dominant histologic findings are those of re- 
generation and repalr. Patterns of late fibrosis 
seen in many chronically tolerated homografts 
are dictated by the earlier localization of most 
serious injury. In long term survivors, the ap- 
pearance of the homografts months or years 
later may range from totally normal to that 
of moderately severe cirrhosis. 
In some of the earlier studies of hepatic homo- 
transplantation, it was suggested that an im- 
portant component of liver rejection might be 
interference with the blood supply either at 
the level of very small (Starzl ef al, 1961, 
McBride et a/, 1962) or of larger vessels 
(Moore et al, 1964). The latter possibility was 
made less llkoly by the subsequent observation 
(Starzl er al, 1965) that significant histologic 
lesions of large intrahepatic arteries were un- 
common in either treated or untreated dogs. 
However, electron micrographs in the latter 
study showed fusion of mononuclear cells to 
the sinusoidal endothellum, reraising the p a n -  
bil~ty of disturbances at the microcirculatorjr 
level. 
Recently, support has been provided for this 
hypothesis (Groth et al, 1967). Sharp falls in 
total liver blood flow were observed with a 
xenon washout technique. In untreated animals, 
these changes were noted concomitantly with 
the diagnosis of rejection. They were progres- 
sive, and generally were not accompanied by 
falls in cardiac output. The hemodynamic alter- 
atlons could be avoided if adequate irnmuno- 
suppression was given or they could even be 
reversed if an existlng rejection was brought 
under control. 
Such research, designed to obtain knowledge 
about the events of rejection may prove to 
have important implications for the care of 
patients. The testing of alternative methods for 
the prevention or treatment of this process is 
an even more clinically oriented kind of inves- 
tigation. During the past few years, many 
agents have been evaluated Of these, none 
has shown more promise than heterologous 
antilymphocyte serum (ALS) and its globulin 
derivitive (ALG), as will soon be reviewed in 
the proceedings from an international Ciba 
symposium held in London in January, 1967, 
(Wolstenholme and O'Connor, 1967). 
The remarkable developments in this field 
cannot be recapitulated here, but it is worth 
noting that mitigation in dogs of liver homo- 
graft rejection has been unequivocally demon- 
strated with both ALS and ALG (Starzl et al, 
1967a). The serum used was raised by irnrnu- 
nizing horses against canlne spleen, thymus, 
and lymphnode lymphocytes. 
The immunosuppressive effectiveness was 
comparable to that of azathioprine in that re- 
jection was prevented altogether in a small 
number of dngs, substantially delayed in the 
majority, and little effected in a minority. Tha 
investigations also showed that these substances 
are potentially dangerous since histopathologic 
evidence of serum sickness nephritis was not 
uncommonly found in the kidneys of animals 
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after a course of either ALS or ALG (Iwasaki 
et ul, 1967). 
Avoreciation of the limitations of ALG ther- 
apy has influenced the way in which heterolo- 
gous immune globulin has been given a clinical 
trial. It has been used for a period limited to the 
first 4 postoperative months and as an adjunct 
to therapy with azathioprine and prednisone. 
There are now indications that treatment with 
ALG, applied in this way, is going to signifi- 
cantly alter the outlook after organ transplan- 
tation in man. The principal evidence has ac- 
cumulated from experience with clinical renal 
homotransplantation. 
In Denver, horse antihuman ALG was first 
used as a n  adjuvant agent more than a year 
ago according to a protocol described elsewhere 
(Starzl et al, 1967b). Between 6 and 12 months 
ago, 21 patients were entered into the study. 
Twenty received renal homografts from blood 
relatives who were not selected on the basis of 
good antigen matching with their recipients; 
the other was provided with a cadaveric homo- 
graft. The quantities of azathioprine used in 
these cases were less than in any comparable 
previous series of patients treated in our insti- 
tutions. More importantly, the requisite average 
doses of prednisone were halved during the 
first 4 postoperative months. Rejection was 
controlled in every instance. Twenty of the 
patients are still alive with good to excellent 
renal function. The only death was due to a 
technical accident. Infectious complications 
were virtually eliminated. It is now predicted 
that the 1 year survival in this group will 
exceed 90 per cent, an expectation which is 
given weight by the fact that the first 8 cases 
have either already passed or are within a few 
weeks of the first post-transplant year, and 
that the next 4 are not far behind. 
More than 1,700 globulin injections have 
been given to these and subsequent reoipients 
of renal homografts without a drug-related 
fatality, a record of safety to which the con- 
comitant administration of azathioprine and 
prednisone undoubtedly contributed. Fever and 
pain at the injection site were the most common 
side reactions. Approximately 15 per cent of 
the patients had some evidence of an anaphy- 
lactic reaction during their course, but these 
were not difficult to 'treat and in several cases 
did not necessitate discontinuation of globulin 
therapy. Renal homograft biopsies after 4 
months from the first 8 cases revealed no evi- 
dence of eithcr serum sickness nephritis or 
Masugi lesions (Starzl et ul, 1%7b). 
These results suggest that a [tool is at hand 
for general improvement of immunosuppres- 
slve management. Whether this will permit 
successful liver transplantation remains to be 
seen. Thus far, 2 patLents have received ortho- 
topic liver homografts while under treatment 
with the same combination of agents described 
above. One was a 29 year old man with a 
hepatoma. The other was a 13 month old child 
w ~ t h  biliary atresia. In both cases, the livers 
were badly damaged by ischemia and func- 
tioned poorly from the outset Death resulted 
from liver failure in 7 and 10 days respectively. 
At autopsy, the predominant histologic ab- 
normalities in the homografts were thought to 
have been caused by the tissue injury inflicted 
at the time of operation. Evidence of rejection 
was minor. 
Histocompatibility Typing 
The prevention of homograft rejection is, of 
course, not solely dependent upon the evolution 
of better immunosuppressive regimens. An al- 
ternative would be to characte~ize the histo- 
compatibility profile of donors and recipients, 
and to consider transplantation only between 
those pairs found to be biologically suitable. 
The st~ingency of immunosuppression could 
presumably be thereby reduced. 
The considerable progress made in identl- 
fying human histocompatibility antigens is well 
known. Reports on the current status of this 
f~eld justly constitute a sizable fraction of the 
program of this meeting. All seem to indicate 
that the day is not far off when a rough idea 
of donor-recipient antigen compatibility wiP 
be obtainable very quickly and with simplified 
techniques. 
That a good antigen match would be highly 
desirable is undeniable. Neverthelas, it is 
known that a bad match does not necessarily 
connote failure, at least after transplantation 
af the kidney. For  this reason, it is by no 
means clear that a perfectly preserved but in- 
compatible organ would be unsuitable. Indeed, 
for reasons described in the flrst section of 
this communication, such a liver would un- 
doubtedly be preferable to a compatible but 
badly injured one. The ideal solution would 
be to  combine the best techniques of liver pre- 
servation with rapid typing. 
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